SARS-CoV-2, COVID-19, and the Eye

Emmett T Cunningham^{1

2

3}, Manfred Zierhut⁴

Affiliations

¹ The Department of Ophthalmology, California Pacific Medical Center, San Francisco, California, USA.
² The Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA.
³ The Francis I. Proctor Foundation, UCSF School of Medicine, San Francisco, California, USA.
⁴ Centre for Ophthalmology, University Tuebingen, Tuebingen, Germany.

Editorial

Emmett T Cunningham et al. Ocul Immunol Inflamm. 2021.

. 2021 May 19;29(4):629-630.

doi: 10.1080/09273948.2021.1970423.

Emmett T Cunningham^{1

2

3}, Manfred Zierhut⁴

¹ The Department of Ophthalmology, California Pacific Medical Center, San Francisco, California, USA.
² The Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA.
³ The Francis I. Proctor Foundation, UCSF School of Medicine, San Francisco, California, USA.
⁴ Centre for Ophthalmology, University Tuebingen, Tuebingen, Germany.

No abstract available

Comment on

An Update on COVID-19 Related Ophthalmic Manifestations.
Jevnikar K, Jaki Mekjavic P, Vidovic Valentincic N, Petrovski G, Globocnik Petrovic M. Jevnikar K, et al. Ocul Immunol Inflamm. 2021 May 19;29(4):684-689. doi: 10.1080/09273948.2021.1896008. Epub 2021 Apr 7. Ocul Immunol Inflamm. 2021. PMID: 33826465